首页> 外国专利> METHOD OF TREATING INTELLECTUAL DISABILITY, AUTISM AND EPILEPSY ASSOCIATED WITH AN IQSEC2 MUTATION AND FOR IDENTIFYING MEDICAMENTS FOR TREATING THE SAME

METHOD OF TREATING INTELLECTUAL DISABILITY, AUTISM AND EPILEPSY ASSOCIATED WITH AN IQSEC2 MUTATION AND FOR IDENTIFYING MEDICAMENTS FOR TREATING THE SAME

机译:与IQSEC2突变相关的智力障碍,自闭症和癫痫的治疗方法,并确定用于治疗该疾病的药物

摘要

The invention provides a method of screening for a potential candidate for treating autism, epilepsy and/or intellectual disability in a subject in need comprising contacting a cell culture or an animal with the potential drug and detecting one or more of the following features: enhancing with the binding of apocalmodulin to the IQ domain of IQSEC2; reducing the production of ARF6-GTP; inhibiting the constitutive activation of guanine nucleotide exchange factor (GEF) IQSEC2;increasing the surface expression of AMPA receptors the brain or a cell; and/or increasing basal synaptic transmission in the brain or the cell. Further provided is a method of treating autism, epilepsy and/or intellectual disability in a subject in need by administering a drug capable of presenting one or more of the above identified features in the described cell and animal models.
机译:本发明提供了一种在有需要的受试者中筛选用于治疗自闭症,癫痫和/或智力残疾的潜在候选者的方法,该方法包括使细胞培养物或动物与潜在药物接触并检测以下一个或多个特征:载脂蛋白调节蛋白与IQSEC2的IQ结构域的结合;减少ARF6-GTP的生产;抑制鸟嘌呤核苷酸交换因子(GEF)IQSEC2的组成型激活;增加大脑或细胞中AMPA受体的表面表达;和/或增加大脑或细胞中的基础突触传递。还提供了通过在所述的细胞和动物模型中施用能够表现出一种或多种上述确定的特征的药物来治疗有需要的受试者中的自闭症,癫痫和/或智力障碍的方法。

著录项

  • 公开/公告号WO2019145957A1

    专利类型

  • 公开/公告日2019-08-01

    原文格式PDF

  • 申请/专利号WO2019IL50106

  • 发明设计人 LEVY ANDREW;

    申请日2019-01-27

  • 分类号G01N33/50;G01N33/68;G01N25/02;A61P25;

  • 国家 WO

  • 入库时间 2022-08-21 11:53:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号